β2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting β2-agonist therapy

Clinical Science

Volumn 96, Issue 3, 1999, Pages 253-259

  Lipworth, B J ^a   Hall, I P ^b   Aziz, I ^a   Tan, K S ^a   Wheatley, A ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Asthma; Bronchial hyperreactivity; Desensitization; Formoterol; Methacholine; Polymorphism; Terbutaline; 2 adrenoceptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FORMOTEROL; METHACHOLINE; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHOCONSTRICTING AGENT; BRONCHODILATING AGENT; DIAGNOSTIC AGENT; ETHANOLAMINE DERIVATIVE; METHACHOLINE CHLORIDE;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; FORCED EXPIRATORY VOLUME; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; ADOLESCENT; DOSE RESPONSE; DRUG ADMINISTRATION; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ETHANOLAMINES; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; TERBUTALINE;

EID: 0033059182     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0960253     Document Type: Article

References (23)

1. 1 National Asthma Education and Prevention Programme. (1997) Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health Publication 97-4051, Bethesda, MD
2. 2 The British Guidelines on asthma management (1997). 1995 review and position statement. Thorax 52 (Suppl. 1), S1-S21
3. 3 Cockcroft, D. W. and Swystun, V. A. (1996) Functional antagonism: tolerance produced by inhaled beta 2 agonists. Thorax 51, 1051-1056
4. 4 Lipworth, B. J. (1997) Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern? Drug Saf. 16, 295-308
5. 5 Greening, A. P., Ind, P. W., Northfield, M. and Shaw, G. (1994) Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344, 219-224
6. 6 Woolcock, A., Lundback, B., Ringdal, N. and Jacques, L. A. (1996) Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 153, 1481-1488
7. 7 Pauwels, R. A., Lofdahl, C. G., Postma, D. S. et al. (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337, 1405-1411
8. 8 Green, S. A., Turki, J., Vegarno, P., Hall, I. P. and Liggett, S. B. (1995) Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airways smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 13, 25-33
9. 9 Green, S. A., Turki, J., Innis, M. and Liggett, S. B. (1994) Amino-terminal polymorphisms of the human beta-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419
10. 10 Tan, K. S., Hall, I. P., Dewar, J., Dow, E. and Lipworth, B. J. (1997) Beta 2-adrenoceptor polymorphism is associated with susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 350, 995-999
11. 11 Martinez, F. D., Graves, P. E., Baldini, M., Solomon, S. and Erickson, R. (1997) Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100, 3184-3188
12. 12 American Thoracic Society. (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136, 225-244
13. 13 Dewar, J., Wilkinson, J., Wheatley, A. et al. (1997) The glutamine 27 beta 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J. Allergy Clin. Immunol. 100, 261-265
14. 14 Beach, J. R., Young, C. L., Avery, H. A. et al. (1993) Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax 148, 239-243
15. 15 American Thoracic Society. (1987) Standardization of spirometry - 1987 update. Am. Rev. Respir. Dis. 136, 1285-1298
16. 16 Dewar, J., Wheatley, A., Venn, A., Morrison, J., Britton, J. and Hall, I. (1998) Beta2-adrenoceptor polymorphisms are in linkage disequilibrium but are not associated with asthma in an adult population. Clin. Exp. Allergy 28, 442-448
17. 17 Aziz, I., Hall, I. P., McFarlane, L. C. and Lipworth, B. J. (1998) Beta 2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. J. Allergy Clin. Immunol. 101, 337-341
18. 18 Aziz, I., Tan, K. S., Hall, I. P., Devlin, M. M. and Lipworth, B. J. (1998) Subsensitivity to bronchoprotection against adenosine monophosphate (AMP) challenge following regular once daily formoterol. Eur. Respir. J. 12, 580-584
19. 19 Simons, F. E. R., Gerstner, T. V. and Cheang, M. S. (1997) Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 99, 655-659
20. 20 Borgstrom, L., Derom, E., Stahl, E., Wahlin-Boll, E. and Pauwels, R. (1996) The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am. J. Respir. Crit. Care Med. 153, 1636-1640
21. 21 Kalra, S., Swystun, V. A., Bhagat, R. and Cockcroft, D. W. (1996) Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 109, 953-956
22. 22 Yates, D. H., Kharitonov, S. A. and Barnes, P. J. (1996) An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Am. J. Respir. Crit. Care Med. 154, 1603-1607
23. 23 Booth, H., Bish, R., Walters, J., Whitehead, F. and Walters, E. H. (1996) Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 51, 1100-1104